290 related articles for article (PubMed ID: 30230669)
1. Access, knowledge and experience with fluorodeoxyglucose positron emission tomography/computed tomography in infection management: a survey of Australia and New Zealand infectious diseases physicians and microbiologists.
Douglas AP; Thursky KA; Worth LJ; Harrison SJ; Hicks RJ; Slavin MA
Intern Med J; 2019 May; 49(5):615-621. PubMed ID: 30230669
[TBL] [Abstract][Full Text] [Related]
2. FDG-PET/CT in managing infection in patients with hematological malignancy: clinician knowledge and experience in Australia.
Douglas AP; Thursky KA; Worth LJ; Harrison SJ; Hicks RJ; Slavin MA
Leuk Lymphoma; 2019 Oct; 60(10):2471-2476. PubMed ID: 30947578
[TBL] [Abstract][Full Text] [Related]
3. The clinical utility of fluorodeoxyglucose-positron emission tomography for investigation of fever in immunocompromised children.
Wang SS; Mechinaud F; Thursky K; Cain T; Lau E; Haeusler GM
J Paediatr Child Health; 2018 May; 54(5):487-492. PubMed ID: 29235187
[TBL] [Abstract][Full Text] [Related]
4. FDG-PET/CT for investigation of pyrexia of unknown origin: a cost of illness analysis.
Liu B; Ma R; Shum E; Hormiz M; Lee ST; Poon AMT; Scott AM
Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1287-1296. PubMed ID: 38057651
[TBL] [Abstract][Full Text] [Related]
5. The role of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in assessment of complex invasive fungal disease and opportunistic co-infections in patients with acute leukemia prior to allogeneic hematopoietic cell transplant.
Longhitano A; Alipour R; Khot A; Bajel A; Antippa P; Slavin M; Thursky K
Transpl Infect Dis; 2021 Jun; 23(3):e13547. PubMed ID: 33338319
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic reference levels for
Alkhybari EM; McEntee MF; Brennan PC; Willowson KP; Kench PL
J Med Imaging Radiat Oncol; 2019 Jun; 63(3):291-299. PubMed ID: 30770654
[TBL] [Abstract][Full Text] [Related]
7. Improving the Diagnostic Performance of
Swart LE; Gomes A; Scholtens AM; Sinha B; Tanis W; Lam MGEH; van der Vlugt MJ; Streukens SAF; Aarntzen EHJG; Bucerius J; van Assen S; Bleeker-Rovers CP; van Geel PP; Krestin GP; van Melle JP; Roos-Hesselink JW; Slart RHJA; Glaudemans AWJM; Budde RPJ
Circulation; 2018 Oct; 138(14):1412-1427. PubMed ID: 30018167
[TBL] [Abstract][Full Text] [Related]
8. Lack of clinical impact of
Liu J; Larcos G; Howle J; Veness M
Australas J Dermatol; 2017 May; 58(2):99-105. PubMed ID: 26459330
[TBL] [Abstract][Full Text] [Related]
9. Present and future role of FDG-PET/CT imaging in the management of breast cancer.
Kitajima K; Miyoshi Y
Jpn J Radiol; 2016 Mar; 34(3):167-80. PubMed ID: 26733340
[TBL] [Abstract][Full Text] [Related]
10. Determining the Diagnostic Value of 18F-Fluorodeoxyglucose Positron Emission/Computed Tomography in Detecting Prosthetic Aortic Graft Infection.
Mitra A; Pencharz D; Davis M; Wagner T
Ann Vasc Surg; 2018 Nov; 53():78-85. PubMed ID: 30012456
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic yield of FDG positron-emission tomography/computed tomography in patients with CEID infection: a pilot study.
Cautela J; Alessandrini S; Cammilleri S; Giorgi R; Richet H; Casalta JP; Habib G; Raoult D; Mundler O; Deharo JC
Europace; 2013 Feb; 15(2):252-7. PubMed ID: 23148119
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the Role of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scanning in the Staging of Patients With Stage IIIB Cervical Carcinoma and the Impact on Treatment Decisions.
Morkel M; Ellmann A; Warwick J; Simonds H
Int J Gynecol Cancer; 2018 Feb; 28(2):379-384. PubMed ID: 29324535
[TBL] [Abstract][Full Text] [Related]
13. Solitary pulmonary nodule evaluation in regions endemic for infectious diseases: Do regional variations impact the effectiveness of fluorodeoxyglucose positron emission tomography/computed tomography.
Purandare NC; Pramesh CS; Agarwal JP; Agrawal A; Shah S; Prabhash K; Karimundackal G; Jiwnani S; Tandon S; Rangarajan V
Indian J Cancer; 2017; 54(1):271-275. PubMed ID: 29199704
[TBL] [Abstract][Full Text] [Related]
14. Merits of FDG PET/CT and Functional Molecular Imaging Over Anatomic Imaging With Echocardiography and CT Angiography for the Diagnosis of Cardiac Device Infections.
Chen W; Sajadi MM; Dilsizian V
JACC Cardiovasc Imaging; 2018 Nov; 11(11):1679-1691. PubMed ID: 30409329
[TBL] [Abstract][Full Text] [Related]
15. FDG PET/CT for Early Detection and Localization of Left Ventricular Assist Device Infection: Impact on Patient Management and Outcome.
Kim J; Feller ED; Chen W; Liang Y; Dilsizian V
JACC Cardiovasc Imaging; 2019 Apr; 12(4):722-729. PubMed ID: 29550312
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of
Hung BT; Wang PW; Su YJ; Huang WC; Chang YH; Huang SH; Chang CC
Int J Infect Dis; 2017 Sep; 62():10-17. PubMed ID: 28652213
[TBL] [Abstract][Full Text] [Related]
17. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
18. FDG PET/CT imaging in detecting and guiding management of invasive fungal infections: a retrospective comparison to conventional CT imaging.
Douglas AP; Thursky KA; Worth LJ; Drummond E; Hogg A; Hicks RJ; Slavin MA
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):166-173. PubMed ID: 29882160
[TBL] [Abstract][Full Text] [Related]
19.
Grobman M; Cohn L; Knapp S; Bryan JN; Reinero C
Vet Radiol Ultrasound; 2018 Jan; 59(1):107-115. PubMed ID: 28925085
[TBL] [Abstract][Full Text] [Related]
20. Expert Consensus on clinical application of FDG PET/CT in infection and inflammation.
Li Y; Wang Q; Wang X; Li X; Wu H; Wang Q; Yao Z; Miao W; Zhu X; Hua F; Zhang X; Cheng C; Zhang W; Hou Q; Li Y; Li XF
Ann Nucl Med; 2020 May; 34(5):369-376. PubMed ID: 32086761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
